Login to Your Account

Pain, Inflammation Specialist Orexo Seeks $40M in Offering

By Cormac Sheridan

Wednesday, May 11, 2011
Shares in Orexo AB dipped 10 percent last week on news that the company was seeking SEK250 million (US$40.1 million) in a discounted rights offering directed at existing shareholders and convertible bond holders.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription